Study on the Transfusional Management of the Patients With Congenital

Status Completed

Clinical Trial Summary

Surgeries of heart disease in adulthood can happen in two specific contexts:

- either for an asymptomatic anomaly, possibly coupled with the onset of symptoms later in life and tardily diagnosed and surgically managed

- either for a malformation treated in childhood and requiring a new intervention in adulthood. In recent years, the number of adult patients with congenital heart disease has been steadily increasing. Advances in diagnostic techniques and surgical treatments have enabled many children to reach adulthood. The number of these patients is now higher than the number of children with congenital heart disease. The number of these patients having had surgery in adulthood is also increasing.

Congenital cardiopathies are numerous, ranging from simpler pathologies such as inter-auricular or inter-ventricular communication, to much more complex pathologies such as situations of univentricular hearts. The surgical treatments of these congenital heart diseases are classified into three groups: initial palliative surgery, initial curative surgery or iterative surgery. Palliative surgery aims to improve the clinical tolerance of the patient to the conditions of his pathology or to prevent complications. The curative surgery restores the physiological circulation, the iterative surgery treats a complication or a degeneration appearing after a curative surgery.

Patients undergoing cardiac surgery frequently receive blood products transfusions during the preoperative, intraoperative, or postoperative periods. Several observational studies have shown that in cardiac surgery, the transfusion of blood derivatives is associated with an increase in post-operative morbidity and mortality.

The objective of this study is to analyze the predictive factors of transfusion in congenital patients operated in adulthood at Brugmann University Hospital, depending on the type of surgery applied (palliative, curative or iterative). The secondary objective will be to assess whether there are any differences with the predictive factors identified in non-congenital patients undergoing cardiac surgery, which could potentially alter the transfusion approach in congenital patients.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03063801
Study type	Observational
Source	Brugmann University Hospital
Contact
Status	Completed
Phase	N/A
Start date	April 1, 2017
Completion date	June 1, 2017

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04136379` - Comparison of Home and Standard Clinic Monitoring of INR in Patients With CHD
Recruiting	`NCT02258724` - Swiss National Registry of Grown up Congenital Heart Disease Patients
Completed	`NCT01212289` - Use of ROTEM® in Pediatric Cardiac Surgical Patients	N/A
Completed	`NCT04090827` - The Transitioning Rural Adolescents to Adult Care Study	N/A
Completed	`NCT03311438` - Oral Health Intervention Program for Children With Congenital Heart Defects	N/A
Active, not recruiting	`NCT04271358` - Peer Coaching Intervention in Young Adults With Congenital Heart Disease	N/A
Terminated	`NCT00451698` - Erythropoietin and Pediatric Cardiac Surgery	N/A
Recruiting	`NCT04106479` - NIRS in Congenital Heart Defects - Correlation With Echocardiography
Recruiting	`NCT04437069` - Improving Patient and Family Health Using Family-Centered Outcomes and Shared Decision-Making	N/A
Completed	`NCT04106154` - Impacting Children's Physical and Mental Health Through Kinesiology Support in Clinical Care	N/A
Recruiting	`NCT03297658` - Electro-acupuncture (EA) in Children Undergoing Procedures for Congenital Heart Defects.	N/A
Recruiting	`NCT04619745` - A Feasibility Study of Physical Activity After Surgical or Catheterization Intervention	N/A
Recruiting	`NCT03512613` - A Pilot Study- Monitoring Cerebral Blood Flow in Neonates With Congenital Heart Defects
Recruiting	`NCT05698277` - Automated Fetal Cardiac Function in Babies Affected by Heart Diseases
Completed	`NCT04056416` - Physical Activity Promotion in Children and Adolescents With Single Ventricle Physiology (MedBike)	N/A
Active, not recruiting	`NCT03110861` - Pulsta® Transcatheter Pulmonary Valve Korean Multicenter Study	N/A
Completed	`NCT02387944` - Bedside Evaluation of Coagulation in Children With Congenital Heart Disease	N/A
Completed	`NCT03348397` - Contegra Versus Pulmonary Homograft for Right Ventricular Outflow Tract Reconstruction in Newborns	N/A
Completed	`NCT02968264` - Tetralogy of Fallot for Life
Completed	`NCT03611374` - Regional Anesthesia for Cardiothoracic Enhanced Recovery (RACER) Study	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Study on the Transfusional Management of the Patients With Congenital Heart Disease Carried Out in Adulthood.

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms